Artusi, Carlo Alberto
Farooqi, Ashar
Romagnolo, Alberto
Marsili, Luca
Balestrino, Roberta
Sokol, Leonard L.
Wang, Lily L.
Zibetti, Maurizio
Duker, Andrew P.
Mandybur, George T.
Lopiano, Leonardo
Merola, Aristide http://orcid.org/0000-0002-5587-726X
Article History
Received: 29 January 2018
Revised: 1 March 2018
Accepted: 2 March 2018
First Online: 6 March 2018
Compliance with ethical standards
:
: Dr. Artusi reports no conflict of interest; Dr. Farooqi reports no conflict of interest; Dr. Romagnolo has received grant support and speaker’s honoraria from AbbVie, speaker honoraria from Chiesi Farmaceutici and travel grants from Lusofarmaco and UCB Pharma; Dr. Marsili reports no conflict of interest; Dr. Balestrino reports no conflict of interest; Dr. Sokol reports no conflict of interest; Dr. Madybur is supported by the Mayfield Education research fund grant; he received honoraria from Medtronic and Boston Scientific; Dr. Wang has no disclosures; Dr. Zibetti has received speaker’s honoraria from Medtronic, Lundbeck, UCB Pharma, and AbbVie; Dr. Duker reports no conflict of interest; Dr. Lopiano has received honoraria for lecturing and travel grants from Medtronic, UCB Pharma, and AbbVie; Dr Merola is supported by NIH (KL2 TR001426) and has received speaker honoraria from CSL Behring, Cynapsus Therapeutics, and AbbVie. He has received grant support from Lundbeck and Abbott.